Cantor Fitzgerald Reiterates Overweight on CVS Health, Maintains $87 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on CVS Health (NYSE:CVS) with a maintained price target of $87.
November 21, 2023 | 3:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald analyst reaffirms Overweight rating on CVS Health with a price target of $87, indicating a positive outlook on the stock.
The reiteration of an Overweight rating by a reputable analyst suggests a positive sentiment towards CVS Health's stock performance. The maintained price target of $87 implies that the analyst believes the stock has the potential to reach or exceed this value in the short term, which could influence investor perception and potentially drive the stock price upward.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100